Atai Beckley, Inc. (ATAI)
7.375
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
7.375
0.00 (0.00%)
After-Hours: 20:00
Atai Beckley Shareholders Equity (Quarterly) : 176.37M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 176.37M |
| March 31, 2026 | 198.68M |
| December 31, 2025 | 221.87M |
| September 30, 2025 | 159.75M |
| June 30, 2025 | 143.74M |
| March 31, 2025 | 152.05M |
| September 30, 2024 | 145.72M |
| June 30, 2024 | 167.89M |
| March 31, 2024 | 222.54M |
| December 31, 2023 | 242.96M |
| September 30, 2023 | 266.28M |
| Date | Value |
|---|---|
| June 30, 2023 | 212.55M |
| March 31, 2023 | 236.82M |
| December 31, 2022 | 260.74M |
| September 30, 2022 | 289.40M |
| June 30, 2022 | 311.68M |
| March 31, 2022 | 346.01M |
| December 31, 2021 | 376.91M |
| September 30, 2021 | 453.19M |
| June 30, 2021 | 474.85M |
| March 31, 2021 | 111.39M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 33.88B |
| GH Research Plc | 359.49M |
| Johnson & Johnson | 84.97B |
| Merck & Co., Inc. | 41.93B |
| Zoetis, Inc. | 3.148B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 264.79M |
| Total Liabilities (Quarterly) | 88.36M |
| Debt to Equity Ratio | 0.0107 |
| Current Ratio | 8.578 |
| Net Debt Paydown Yield | 0.28% |